A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy

NCT07475754 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: Rituxan treatment

Sponsor

Peking Union Medical College Hospital